Drug Survival of IL-17 and IL-23 Inhibitors for Psoriasis: A Systematic Review and Meta-Analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Drug Survival of IL-17 and IL-23 Inhibitors for Psoriasis: A Systematic Review and Meta-Analysis ; volume:84 ; number:5 ; day:17 ; month:4 ; year:2024 ; pages:565-578 ; date:5.2024
Drugs ; 84, Heft 5 (17.4.2024), 565-578, 5.2024
- Creator
-
Thomas, Sarah E.
Barenbrug, Liana
Hannink, Gerjon
Seyger, Marieke M. B.
Jong, Elke M. G. J. de
Reek, Juul M. P. A. van den
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40265-024-02028-1
- URN
-
urn:nbn:de:101:1-2409160919543.900970072401
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:39 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Thomas, Sarah E.
- Barenbrug, Liana
- Hannink, Gerjon
- Seyger, Marieke M. B.
- Jong, Elke M. G. J. de
- Reek, Juul M. P. A. van den
- SpringerLink (Online service)
Other Objects (12)
Comment on: Drug Survival of IL‑12/23, IL‑17 and IL‑23 Inhibitors for Psoriasis Treatment: A Retrospective Multi‑Country, Multicentric Cohort Study
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study
The role of theproinflammatory cytokines IL-17, IL-6 and IL-1 in (IMQ-induced) psoriasis
Single‐cell transcriptomics reveals prominent expression of IL‐14, IL‐18, and IL‐32 in psoriasis
Regulation of IL-22BP in psoriasis
Der erste selektive IL-23-Inhibitor Guselkumab : Therapie der Plaque-psoriasis erwachsener Patienten
Expression analysis of IL-22BP in psoriasis and its mouse model : = Untersuchung der Expression von IL-22BP in Psoriasis und deren Mausmodell
The psoriasis-associated IL-17A induces and cooperates with IL-36 cytokines to control keratinocyte differentiation and function
The IL-17A - IL-36 cytokine network : an amplifying mechanism in psoriasis
Another anti-interleukin (IL)-17 inhibitor: is there an advantage of blocking IL-17A and IL-17F?
The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis
Crohn’s disease exacerbated by IL-17 inhibitors in patients with psoriasis: a case report
Comment on: Drug Survival of IL‑12/23, IL‑17 and IL‑23 Inhibitors for Psoriasis Treatment: A Retrospective Multi‑Country, Multicentric Cohort Study
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study
The role of theproinflammatory cytokines IL-17, IL-6 and IL-1 in (IMQ-induced) psoriasis
Single‐cell transcriptomics reveals prominent expression of IL‐14, IL‐18, and IL‐32 in psoriasis
Regulation of IL-22BP in psoriasis
Der erste selektive IL-23-Inhibitor Guselkumab : Therapie der Plaque-psoriasis erwachsener Patienten
Expression analysis of IL-22BP in psoriasis and its mouse model : = Untersuchung der Expression von IL-22BP in Psoriasis und deren Mausmodell
The psoriasis-associated IL-17A induces and cooperates with IL-36 cytokines to control keratinocyte differentiation and function
The IL-17A - IL-36 cytokine network : an amplifying mechanism in psoriasis
Another anti-interleukin (IL)-17 inhibitor: is there an advantage of blocking IL-17A and IL-17F?
The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis
Crohn’s disease exacerbated by IL-17 inhibitors in patients with psoriasis: a case report
Comment on: Drug Survival of IL‑12/23, IL‑17 and IL‑23 Inhibitors for Psoriasis Treatment: A Retrospective Multi‑Country, Multicentric Cohort Study
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study
The role of theproinflammatory cytokines IL-17, IL-6 and IL-1 in (IMQ-induced) psoriasis
Single‐cell transcriptomics reveals prominent expression of IL‐14, IL‐18, and IL‐32 in psoriasis
Regulation of IL-22BP in psoriasis
Der erste selektive IL-23-Inhibitor Guselkumab : Therapie der Plaque-psoriasis erwachsener Patienten
Expression analysis of IL-22BP in psoriasis and its mouse model : = Untersuchung der Expression von IL-22BP in Psoriasis und deren Mausmodell
The psoriasis-associated IL-17A induces and cooperates with IL-36 cytokines to control keratinocyte differentiation and function
The IL-17A - IL-36 cytokine network : an amplifying mechanism in psoriasis
Another anti-interleukin (IL)-17 inhibitor: is there an advantage of blocking IL-17A and IL-17F?
The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis